Effect of Kyejakjimo-tangkami (Guishaozhimu-tangjiawei) on Osteoarthritis

계작지모양가미방(桂芍知母湯加味方)이 골관절염에 미치는 영향

  • Published : 2013.10.31


Objectives The purpose of this study is to prove the effect of Kyejakjimotangkami(KMK) on osteoarthritis. Methods We checked antioxidant activity and measured production of $IL-1{\beta}$, IL-6, TNF-${\alpha}$ in RAW 264.7 cell after treat by KMK. Then we measured hind paw weight of Wister Rat with arthritis induced by MIA after KMK oral administration, checked Prostaglandin E2, IL-$1{\beta}$, IL-6, TNF-${\alpha}$, Osteocalcin, TIMP-1, MMP-9, LTB-4 in serum, ran histopathological test and ${\mu}CT$-arthrography. Results 1. DPPH radical Scavenging was increased depend on concentration of KMK ethanol extract in RAW 264.7 cell. 2. Production of NO was significantly decreased by KMK ethanol extract on concentration of $200{\mu}g/ml$ in RAW 264.7 cell. 3. Production of IL-$1{\beta}$ was significantly decreased by KMK ethanol extract on concentration of $200{\mu}g/ml$. And Production of IL-6, TNF-${\alpha}$ were significantly decreased KMK ethanol extract of every concentration in RAW 264.7 cell. 4. Result of checking hind paw weight when administered KMK ethanol extract to Wister Rat with arthritis induced by MIA was significantly higher than control group and similar to normal group. 5. Production of Prostaglandin E2, IL-$1{\beta}$, Osteocalcin, TIMP-1, MMP-9 and LTB-4 in serum was significantly decreased by KMK ethanol extract after administerd to Wister Rat with arthritis induced by MIA. 6. In Hematoxylin & Eosin staining and Safranin-O staining, we could find inflammation of synovial cell, infiltration of macrophage and granulocyte and degeneration of cartilage and bone were decreased in comparison with control group. 7. When checked cartilage volume to examine degree of cartilage degeneration using ${\mu}CT$-arthrography, volume of cartilage was increased in comparison with control group. Conclusions Comparison of the results for this study showed that KMK ethanol extract have anti-inflammatory effectiveness and can protect cartilage and bone. So we expect that KMK can be used as a effective drugs for osteoarthritis.


Kyejakjimotang (KMK);Osteoarthritis;Cytokine;MIA induced arthritis;Cartilage


  1. 대한정형외과학회. 정형외과학. 서울:최신의학사. 2006:195-201, 253-61, 517.
  2. Merck Research Laboratories. 머크 임상의학 진단 및 치료. 서울:도서출판 한우리. 2002:487.
  3. Auw Yang KG, Saris DBF, Dhert WJA, Verbout AJ. Osteoarthritis of the knee: current treatment options and future directions. Current Orthopaedics. 2004;18:311-20. https://doi.org/10.1016/j.cuor.2004.04.005
  4. 양창헌. 흔히 접하는 비스테로이드성 항염증약물과 위장관 질환. 동국의학. 2003;10(2):190-9.
  5. 한재동, 신주호, 황현철, 김도영, 조원호, 임군일. 골 용해에 관여하는 세포성장인자의 상호작용. 대한정형외과연구학회지. 2000;3(2):125-32.
  6. 한방재활의학과학회. 한방재활의학. 서울:군자출판사. 2006:79-97.
  7. Laufer S, Greim C, Bertsche T. An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs. Osteoarthritis and Cartilage. 2002;10:961-7. https://doi.org/10.1053/joca.2002.0851
  8. Maier JA, Brugel TA, Clark MP, Sabat M, Golebiowski A, Bokkland RG, Laufersweiler MJ, Laughlin SK, VanRens JC, De B, Hsieh LC, Brown KK, Juergens K, Walter RL, Janusz MJ. Development of N-2,4-pyrimidine-N-phenyl-N'-alkylureas as orally active inhibitors of tumor necrosis factor alpha (TNF-${\alpha}$) synthesis. Part2. Bioorganic & Medicinal Chemistry Letters. 2006;16:3514-8. https://doi.org/10.1016/j.bmcl.2006.03.096
  9. 권재식, 김기현, 김형태, 박응호, 서성훈. 痺症. 서울:정담. 1993:207-71.
  10. 김미려, 허수영, 박기현. 퇴행성 슬관절염에 대한 동서의학적 비교. 대한동의학술원 논문집. 1994;4(1):711-22.
  11. 張仲景. 金匱要略方論. 臺北:台聯國風出版社. 1973:32-3.
  12. 김순신, 김혜경, 최종원, 이정규. 계작지모탕(桂芍知母湯)의 소염.진통작용 및 Alcohol성 고뇨산혈증(高尿酸血症)에 미치는 영향. 생약학회지. 1995;26(1):66-73.
  13. 전국 한의과 대학 본초학교수 공편저. 本草學. 서울:영림사. 1999:427, 445.
  14. 전국의과대학교수. 오늘의 진단 및 치료. 서울:한우리. 1999:876-97.
  15. Ehrlich MG, Armstrong AL, Treadwell BV. The role of proteases in the pathogenesis of osteoarthritis. J Rheumatol. 1987;14:30-2.
  16. Heinegard D. Cartilage Proteoglycans in degenerative joint disease. J Rheumatol. 1987;14:110-2.
  17. Howell DS. Pathogenesis of osteoarthris. Am J Med. 1986;80:24-8. https://doi.org/10.1016/0002-9343(86)90075-6
  18. 해리슨 번역 편찬위원회. 해리슨 내과학. 서울:정담출판사. 2006:1821-7.
  19. 王琦 外. 黃帝內經 素問今釋. 서울:醫聖堂. 1994:1, 60, 164, 206-11, 412.
  20. 대한병리학회. 병리학. 서울:고문사. 2003:1167-9.
  21. Takanori Kikuchi, Tomohiro Sakuta, Toshijiro Yamaguchi. Intra-articular injection of collagenase induces experimental osteoarthritis in mature rabbits. Osteoarthritis and Cartilage. 1998;6:177-86. https://doi.org/10.1053/joca.1998.0110
  22. 정수태, 강봉균. 골관절염의 원인과 치료. 가정의학회지. 2000;21(supple):824-7.
  23. 張介賓. 張氏類經. 서울:成補社. 1982:14-20, 815-9.
  24. 巢元方. 諸病源候論. 台北:人民衛生出版社. 1979:576, 644.
  25. 張로玉. 張氏醫通上冊. 台北:自由出版社. 1964:18.
  26. 최정식, 송태원. 鷄血藤이 collagen으로 유발된 생쥐의 관절염억제에 관한 연구. 대한본초학회지. 2003;18(3):79-88.
  27. 서해경, 오민석, 김동희. 류마토이드 關節炎 患者 滑膜細胞에 대한 鷄血藤의 免疫反應. 동의생리병리학회지. 2003;17(3):780-6.
  28. 김현수, 홍서영, 허동석, 오민석. 관절6호방이 Type II collagen으로 유발된 관절염에 미치는 영향. 동의생리병리학회지. 2009;23(5):1003-11.
  29. Kalbhen DA, Blum U. Theoretisches Koncept und experimentelle bestatigung fur ein neues arthros-modell am versuchstier. Arzneimittelforshung Drug Res. 1977;27:527-31.
  30. Kalbhen DA. Chemical model of osteoarthritis -apharmacological evaluation. Rheumatology. 1987;14:130-1.
  31. Guingampc, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate -induced experimental osteoarthritis. A dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum. 1997;40:1670-9. https://doi.org/10.1002/art.1780400917
  32. McCartney-Francis NL, Song X, Mizel DE, Wahl SM. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease. J Immunol. 2001;166(4):2734-40. https://doi.org/10.4049/jimmunol.166.4.2734
  33. Van der Kraan PM, Vitters EL, Van de Putte LBA, Van den Berg WB. Development of osteoarthritic lesions in mice by 'Metabloic' and 'Mechanical' alterations in the knee joints. Am J Pathol. 1989;35:1001-14.
  34. Fu S, Gebicki S, Jessep W, Gebicki JM, Dean RT. Biological fate of amino acid, peptide and protein hydroperoxides. Biochem J. 1995;31(3):821-7.
  35. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthtitis Rheum. 1998;41(7):1141-51. https://doi.org/10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S
  36. McCord JM. The evolution of free radicals and oxidative stress. Am J Med. 2000;108(8):652-9. https://doi.org/10.1016/S0002-9343(00)00412-5
  37. Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007;38:151-6. https://doi.org/10.1016/j.cyto.2007.06.001
  38. Lopez-Armada MJ, Carames B, Martin MA, Cillero-pastor B, Lires-Dean M, Fuentes-Boquete I, Arenas J, Blanco FJ. Mitochondrial activity is modulated by TNF-${\alpha}$ and IL-$1{\beta}$ in normal human chondrocyte cells. Osteoarthritis and Cartilige. 2006;14:1011-22. https://doi.org/10.1016/j.joca.2006.03.008
  39. Williams RO, Paleolog E, Feldmann M. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases. Current Opinion in Pharmacology. 2007;7:412-7. https://doi.org/10.1016/j.coph.2007.06.001
  40. Simi T. Inhibition of IL-6, IL-10 signaling and star activation by inflammatory and stress pathways. J Immunol. 2000;165:5227-37. https://doi.org/10.4049/jimmunol.165.9.5227
  41. Cryer B, Dubois A. The advent of highly selective inhibitors of cyclooxygenase-a review. Prostaglandins other Lipid Mediat. 1998;56(5-6):341-61. https://doi.org/10.1016/S0090-6980(98)00064-1
  42. Jacqueline Uson, Alejiandro Balsa. Dorsa Pascal-Salcedo : Soluble IL-6 Receptor and differant Arthropathies. J Rheumatol. 1997;24:2069-75.
  43. Dayer JM, Rochemonteix B, Burrus B, Demczuk S, Dinarello CA. Human recombinant IL-1 stimulates collagenase and prostagiandin E production by human synovial cells, J of Clinical Investigation. 1986;77:645-8. https://doi.org/10.1172/JCI112350
  44. Feldmann M, Pusey CD. Is there a role for TNF-${\alpha}$ in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons from other chronic inflammatory diseases. J Am Soc Nephrol. 2006;17:1243-52. https://doi.org/10.1681/ASN.2005121359
  45. Horton JK, Williams AS, Smith-Phillips Z, Martin RC, O'Beirne G. Intracellular measurement of prostaglandin E2: Effect of anti-inflammatory drugs cyclooxygenase activity and prostanoid expression. Anal Biochem. 1999;271(1):18-28. https://doi.org/10.1006/abio.1999.4118
  46. Isgaard J, Moller C, Isaksson OG, Nilsson A, Methews LS, Norstedt G. Regulation of Insulin-like Growth factor messenger ribonucleic in rat growth plate by growth hormone. Endocrinology. 1988;122:1515-20. https://doi.org/10.1210/endo-122-4-1515
  47. Goupille P, Jayson M, Valat JP, Freemont AJ. Matrix metalloproteinases; The clue to intervertebral disc degeneration. Spine. 1998;23:1612-26. https://doi.org/10.1097/00007632-199807150-00021
  48. Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 1977;389:77-81.
  49. Peters-Golden M, Henderson WR Jr. Leukotriene. N Engl J Med. 2007;18:1841-54.
  50. 이정민, 임미정, RANKL 유도성 파골세포분화에 있어서 LTB4의 역할 규명. J Pharm Sci S. W. U. 2010;25:38-42.